Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
treatment crawled date : 2022 - 09 - 15 save search
GBT Supports the Sickle Cell Disease Treatment Centers Act of 2022
Published: 2022-09-15 (Crawled : 23:00) - globenewswire.com
GBT | $68.49 0.02% -0.02%
|
Health Technology
|
| O: -0.1%
H: 0.1%
C: -0.13%
treatment disease
Revance to Present Data from Phase 2 JUNIPER Clinical Trial Evaluating DAXXIFY™ (DaxibotulinumtoxinA-lanm) Injection for the Treatment of Upper Limb Spasticity at the International Congress of Parkinson and Movement Disorder Society (MDS)
Published: 2022-09-15 (Crawled : 22:00) - biospace.com/
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: -0.11%
H: 3.08%
C: 1.38%
RVNC | $3.8 1.06% 1.05% 1.6M
|
Health Technology
|
| O: -0.8%
H: 0.0%
C: -3.3%
treatment parkinson trial injection international
GigaGen Awarded Contract by U.S. Department of Defense to Discover Synthetic Human Antibody Treatments for High-Priority Toxins and Pathogens
Published: 2022-09-15 (Crawled : 15:00) - biospace.com/
GRFS | News | $6.53 -0.76% -0.77% 760K
|
Health Technology
|
| O: 0.24%
H: 1.33%
C: 1.33%
defense antibody contract pathogens
New treatment for rare cancer cholangiocarcinoma approved in Australia
Published: 2022-09-15 (Crawled : 14:20) - biospace.com/
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: -0.29%
H: 1.73%
C: 1.11%
treatment rare australia approved cancer
Omeros Corporation Reports Narsoplimab Treatment Results in Critically Ill COVID-19 Patients in I-SPY COVID Trial
Published: 2022-09-15 (Crawled : 14:20) - biospace.com/
OMER | $3.22 -3.59% -3.73% 430K
|
Health Technology
|
| O: -5.57%
H: 2.16%
C: -21.61%
covid-19 treatment covid trial corporation results
I-SPY COVID Trial Sponsored by Quantum Leap Healthcare Collaborative Reports Assessment of Narsoplimab for Treatment of Critically Ill Patients With COVID-19
Published: 2022-09-15 (Crawled : 14:00) - biospace.com/
OMER | $3.22 -3.59% -3.73% 430K
|
Health Technology
|
| O: -5.57%
H: 2.16%
C: -21.61%
covid-19 treatment quantum covid trial leap
UpHealth's Transformations Treatment Center Awarded Top Honors on Newsweek's America's Best Addiction Treatment Centers List
Published: 2022-09-15 (Crawled : 14:00) - prnewswire.com
UPH | $0.3 9.13% 0.0% 350K
|
Professional, Scientific, and T...
|
| O: -3.0%
H: 5.11%
C: 1.81%
treatment
Shuttle Pharmaceuticals Awarded New HDAC Inhibitor Patents for Cancer Treatment
Published: 2022-09-15 (Crawled : 13:20) - biospace.com/
SHPH | $0.4099 -2.69% 11K
|
|
| O: 1.36%
H: 0.0%
C: 0.0%
treatment cancer
Bristol Myers Squibb Announces Adjuvant Treatment with Opdivo (nivolumab) Demonstrated Statistically Significant and Clinically Meaningful Improvement in Recurrence-Free Survival (RFS)
Published: 2022-09-15 (Crawled : 13:00) - biospace.com/
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.24%
H: 2.12%
C: 1.61%
treatment opdivo nivolumab
Kymera Therapeutics Receives FDA Orphan Drug Designation for KT-333, a First-in-Class, Investigational STAT3 Degrader for the Treatment of Cutaneous T-Cell Lymphoma
Published: 2022-09-15 (Crawled : 12:00) - biospace.com/
KYMR | $35.16 4.15% 3.98% 620K
|
Health Technology
|
| O: 0.25%
H: 6.06%
C: 3.16%
kt-333 treatment fda designation drug t-cell therapeutics
Mallinckrodt Receives U.S. FDA Approval for Terlivaz® (terlipressin) for injection for the Treatment of Hepatorenal Syndrome (HRS)
Published: 2022-09-15 (Crawled : 03:00) - prnewswire.com
MNKPF | $17.25
|
n/a
|
| O: 10.71%
H: 16.13%
C: 15.81%
terlivaz treatment fda approval injection
MediciNova Receives Issue Notification for a New Patent Covering MN-166 (ibudilast) for the Treatment of Glioblastoma
Published: 2022-09-14 (Crawled : 00:00) - globenewswire.com
MNOV | $1.445 1.05% 1.04% 21K
|
Health Technology
|
| O: -0.46%
H: 4.65%
C: 2.33%
mn-166 treatment patent glioblastoma
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.